Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130) on September 21, 2023. The Pharmaceutical business generated annual sales of KRW 313.9 billion in 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60,500 KRW | +0.17% | +3.42% | -10.10% |
Apr. 26 | SK chemicals Unveils Blueprint for Circular Recycle? and Solutions | CI |
Apr. 18 | SK Chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.10% | 792M | |
+4.25% | 40.01B | |
-19.34% | 22.02B | |
-13.51% | 13.37B | |
-10.91% | 9.95B | |
-10.82% | 9.48B | |
+11.43% | 7.7B | |
+12.15% | 7B | |
-26.77% | 5.56B | |
-29.83% | 3.28B |
- Stock Market
- Equities
- A285130 Stock
- News SK Chemicals Co.,Ltd
- Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd.